Skip to main content

Press Release

2018-11-2

IK Investment Partners to support SCHEMA Group

Category
Press Releases
Share

IK Investment Partners (“IK”) is pleased to announce that the IK Small Cap II Fund together with the founders has reached an agreement to acquire SCHEMA Group (“SCHEMA” or “the Company”), a leading developer and provider of software solutions for demanding product- and process-related content. Financial terms of the transaction are not disclosed, and the completion of the transaction is subject to regulatory approval.

Founded in 1995 by Marcus Kesseler and Stefan Freisler, SCHEMA provides sophisticated component content management system (CCMS) software for creating modular documentation in technical content and other editing contexts and targets a broad range of different global industries such as engineering, pharmaceuticals and medical technology. CCMS solutions are required to efficiently master the high complexity when writing, managing, and publishing product-related content while at the same time ensuring process security. The software addresses the increasing global complexity created by tightening of regulations, digitalisation and globalisation trends as well as shorter product lifecycles. SCHEMA is an innovation leader and has set international industry standards regarding the range of features and standardisation of CCMS over the last 20 years. Its products enable customers to realise substantial cost and time savings and increase the content processes efficiency.

The acquisition of SCHEMA represents IK’s second investment in the DACH region for the newly established IK Small Cap II Fund . IK will work with the founders and SCHEMA’s management to accelerate the Company’s organic growth strategy in its existing and new markets and will continue to invest in its operations, product development, and sales activities.

Stefan Freisler, Founder of SCHEMA, said:
”We are very proud of the Company’s progress and the high loyalty of our customers. With IK we have found the right partner to further expand SCHEMA’s market position and embark on a new chapter.”

Marcus Kesseler, Founder of SCHEMA, commented:
”IK shares our vision for the future strategic roadmap and opportunities of SCHEMA. Their support and experience will be a true added value for our success and we look forward to working together with IK to continuously develop the Company and its product offering.”

Nils Pohlmann, Partner at IK Investment Partners and advisor to the IK Small Cap II Fund said:
“SCHEMA is an innovative niche market leader addressing global trends which will become fundamentally important to every company. Its impressive blue-chip and loyal client base demonstrates SCHEMA’s success in providing efficiency and cost benefits to its customers. We are excited to support the Company’s growth and expansion strategy going forward and to work closely with the founders and its strong management team.”

For further questions, please contact:

SCHEMA Group
Marcus Kesseler, Managing Director
Stefan Freisler, Managing Director
+49 911 586861 0

IK Investment Partners
Nils Pohlmann
Partner
Phone: +49 40 369 88 50

Mikaela Murekian
Director Communications & ESG
Phone: +44 77 87 573 566
mikaela.murekian@ikinvest.com

About IK Investment Partners

IK Investment Partners (“IK”) is a Pan-European private equity firm focused on investments in the Nordics, DACH region, France, and Benelux. Since 1989, IK has raised more than €9.5 billion of capital and invested in over 120 European companies. IK funds support companies with strong underlying potential, partnering with management teams and investors to create robust, well-positioned businesses with excellent long-term prospects. For more information, visit www.ikinvest.com

About SCHEMA Group

Founded by Marcus Kesseler and Stefan Freisler in 1995, the SCHEMA Group has been providing software solutions for complex documentation for more than 20 years. The Company is headquartered in Nuremberg, Germany. For more information, visit www.schema.de

Recent News

2024-12-20
IK Partners to sell Mecenat to Inflexion
Read More
2024-12-19
Eurobio Scientific: EB Development obtains a significant majority of the capital with 88.9% held at the end of the Reopened Offer to continue its development with NextStage AM and IK Partners
Read More
2024-12-16
IK Partners to acquire majority stake in Dains alongside management
Read More
2024-12-12
Rivean Capital has acquired a majority stake in Acture Group from IK Partners
Read More